Skip to main content
SpringerLink
Log in

Long-term survival of a patient with metastatic melanoma treated with nivolumab and vemurafenib, with the development of vitiligo

  • Correspondence
  • Published:
European Journal of Dermatology

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Robert C, Long GV, Brady B, et al. Nivolumab in previously untreated melanoma without BRAF mutation. N Engl Med J 2015; 372: 320–30.

    Article  CAS  Google Scholar 

  2. Chapman PB, Hauschild A, Robert C, et al. Improved survival with vemurafenib in melanoma with BRAF V600E mutation. N Engl Med J 2011; 364: 2507–16.

    Article  CAS  Google Scholar 

  3. Fonkem E, Uhlmann EJ, Floyd SR, et al. Melanoma brain metastasis: overview of current management and emerging targeted therapies. Expert Rev Neurother 2012; 12: 1207–15.

    Article  CAS  PubMed  Google Scholar 

  4. Byrne KT, Turk MJ. New perspective on the role of vitiligo in immune responses to melanoma. Oncotarget 2011; 2: 684–94.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Teulings HE, Limpens J, Jansen SN, et al. Vitiligo-like depigmentation in patients with stage III-IV melanoma receiving immunotherapy and its association with survival: a systematic review and meta-analysis. J Clin Oncol 2015; 33: 773–81.

    Article  CAS  PubMed  Google Scholar 

  6. Maio M. Melanoma as a model tumour for immuno-oncology. Ann Oncol 2012; 23: 10–4.

    Article  Google Scholar 

  7. Ascierto PA, Simeone E, Sileni CV, et al. Sequential treatment with ipilimumab and BRAF inhibitors in patients with metastatic melanoma: data from the Italian cohort of the ipilimumab expanded access program. Cancer Invest 2014; 32: 144–9.

    Article  CAS  PubMed  Google Scholar 

  8. Wyluda EJ, Cheng J, Schell TD, et al. Durable complete responses off all treatment in patients with metastatic malignant melanoma after sequential immunotherapy followed by a finite course of BRAF inhibitor therapy. Cancer Biol Ther 2015; 16: 662–70.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Ruiz-Villaverde R, Sanchez-Cano D. Can vemurafenib induce vitiligo in metastatic melanoma patients? Balkan Med J 2016; 33: 115–6.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Alonso-Castro L, Ríos-Buceta L, Vano-Galva S, Moreno C, Soria-Rivas A, Jaén P. Vitiligo in 2 patients receiving vemurafenib for metastatic melanoma. J Am Acad Dermatol 2013; 69: 28–9.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho Chuo-ku, Kobe, Japan

    Takeshi Fukumoto, Susumu Fujiwara, Masanobu Sakaguchi, Masahiro Oka & Chikako Nishigori

  2. Division of Medical Oncology/Hematology, Department of Medicine, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho Chuo-ku, Kobe, Japan

    Naomi Kiyota

  3. Division of Radiation Oncology, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho Chuo-ku, Kobe, Japan

    Yasuo Ejima

  4. Division of Surgery, Shiso Municipal Hospital, 93 Yamasaki-cho, Shiso-shi, Japan

    Koichi Nakajima

Authors
  1. Takeshi Fukumoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Susumu Fujiwara
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Masanobu Sakaguchi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Masahiro Oka
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Naomi Kiyota
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Yasuo Ejima
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Koichi Nakajima
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Chikako Nishigori
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Takeshi Fukumoto.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Fukumoto, T., Fujiwara, S., Sakaguchi, M. et al. Long-term survival of a patient with metastatic melanoma treated with nivolumab and vemurafenib, with the development of vitiligo. Eur J Dermatol 27, 177–178 (2017). https://doi.org/10.1684/ejd.2016.2925

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1684/ejd.2016.2925

Search

Navigation